Sanofi Pasteur’s Adacel (Tdap) Vaccine FDA Approved for Repeat Vaccination after 8 Years

The Food and Drug Administration recently approved the Adacel (Tdap) vaccine to be administered as soon as 8 years after a previous dose. Adacel, manufactured by Sanofi Pasteur, provides immunity to tetanus, diphtheria, and pertussis. The vaccine is approved for patients ages 10-64, and is available in a syringe made without natural rubber latex.

The current CDC recommendations for Tdap are as follows:

  • Adolescents should receive a single dose, preferably at age 11 or 12
  • All pregnant women should receive a single dose during pregnancy, preferably between weeks 27 and 36. By receiving this vaccine, pregnant mothers pass antibodies to their babies, reducing the risk of whooping cough.
  • Adults should receive a single dose of Tdap followed by a booster Td every 10 years.

FDA approval was based on clinical data from a study that showed no significant differences in adverse events when adults received Adacel versus Td 8-12 years after a previous dose of Adacel.  The approval of Adacel administration every 8 years provides more flexibility for physicians in both vaccine purchasing decisions and immunizations scheduling. Sanofi has provided study results to the CDC for consideration in future recommendations.

For more information or to purchase Adacel or any other immunization, visit our website or send us an email

AAP Releases “Immunization Information Technology Guide” for pediatricians

At CPP’s recent Vaccine Management Summit, 2D barcoding stood out as a topic of interest among attendees. CPP members will find a new AAP guide helpful as they continue to learn about this technology.

The AAP recently released a guide for pediatricians with information on two key information technology topics: immunization information systems and two dimensional barcoding. In addition, the AAP provides a detailed website for both topics that summarizes the information found in the new guide and provides relevant links.

Immunization Information Systems, also known as vaccine or immunization registries, are confidential computerized systems that capture vaccination data across the lifespan within a certain geographical area. The use of these systems can reduce healthcare costs and improve patient care. The benefits to pediatric practices of using these systems include minimizing duplicate vaccine administration, aiding in recalling patients overdue for vaccinations, reminding patients of upcoming immunizations, and identifying vulnerable patients during a disease outbreak.

Two Dimensional Barcode Scanning Technology can be used with the majority of pediatric vaccines. Recent studies show that the use of 2D scanning increase accuracy in vaccine documentation and reduces documentation time by an average of 21 seconds. 2D barcode scanning improves practice efficiency, increases vaccine inventory accuracy, and assists in proper billing. In addition, the technology benefits patients by improving safety and documentation, reducing errors, and identifying expired vaccines before they are administered to patients. The AAP’s 2D barcoding resources include practice uses, choosing a scanner, and getting the scanner to “work.”   

For practices not yet ready to implement 2D barcoding, CPP has other resources to help manage your vaccine inventory including a Vaccine Inventory Reconciliation Sheet. These resources can be found on our website.